Microbot Medical Inc. (MBOT) - צמיחת רווח למניה משנה לשנה בשנים עשר החודשים האחרונים
The quarterly EPS growth trend helps assess the business resilience of Microbot Medical Inc. (MBOT) amid vulnerable supply chains and regulatory barriers. Innovative vascular microrobots provide the company with significant pricing power, while its environmental profile is limited to electronics disposal. Meanwhile, the 12.40 indicator suggests the asset is trading in a sideways range, forming a base for quantitative alpha analysis.
MBOT (Microbot Medical, Inc): פילוחים אנליטיים ודוחות לפי אינדיקטורים
Quarterly EPS growth measures the dynamics of net profit per share, reflecting the actual speed of business scaling. By analyzing the trend of quarterly earnings per share growth, an investor assesses the sustainability of fundamental development. This metric is calculated as the percentage change in profit over a period, smoothing time lags through daily recalculation. For Microbot Medical Inc. (MBOT), such indicators confirm the effectiveness of integrating Liberty microrobots into cardiology practice. Technological synergy with clinics directly determines the future profitability of the company.
